{"id":"W3088563759","doi":"10.1016/j.annonc.2020.08.2084","title":"690TiP A phase III, randomized, double-blind trial of nivolumab or placebo combined with docetaxel for metastatic castration-resistant prostate cancer (mCRPC; CheckMate 7DX)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Docetaxel; Medicine; Nivolumab; Prostate cancer; Oncology; Internal medicine; Enzalutamide; Chemotherapy; Placebo; Cancer; Immunotherapy; Androgen receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007357292,0.001339723,0.002088566,0.0004002711,0.000437011,0.0009413047,0.0008060352,0.001532416,0.01929454],"category_scores_gemma":[0.0007079081,0.0007762811,0.001403537,0.0003114286,0.0008606443,0.0006620598,0.0002737637,0.00284913,0.002691297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006399701,"about_ca_system_score_gemma":0.001345145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001847592,"about_ca_topic_score_gemma":0.005376929,"domain_scores_codex":[0.9997388,0.0001120047,0.0000136806,0.00005547682,0.00002152659,0.00005844518],"domain_scores_gemma":[0.9997215,0.00006469482,0.00004006586,0.00001845357,0.00002311588,0.0001321593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9594788,0.006954714,0.0003211701,0.0008114767,0.0008291599,0.00002748784,0.00002939317,0.0002937923,0.004465421,0.000192992,0.00328255,0.023313],"study_design_scores_gemma":[0.9554088,0.04141256,0.0009320679,0.00002433423,0.0003012271,0.00001859181,0.00001112038,0.0003078881,0.0004251844,0.00008022836,0.00106561,0.0000123993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9598004,0.008972732,0.001346838,0.001150437,0.002103918,0.007734993,0.004787575,0.0008010201,0.01330219],"genre_scores_gemma":[0.967231,0.003919241,0.002629752,0.002406817,0.0005733815,0.004788432,0.003752477,0.00008577669,0.01461308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01929454,"threshold_uncertainty_score":0.06454664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2333752153737564,"score_gpt":0.4744678595961537,"score_spread":0.2410926442223974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}